Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K/AKT/mTOR signaling
T W. Grunt, G L. Mariani - Current cancer drug targets, 2013 - benthamdirect.com
Breast cancer is one of the most prevalent and devastating malignant diseases in women
worldwide. Fortunately, while breast cancer incidence is still increasing, its death rate is …
worldwide. Fortunately, while breast cancer incidence is still increasing, its death rate is …
[引用][C] Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling
TW Grunt, GL Mariani - Current Cancer Drug Targets, 2013 - cir.nii.ac.jp
Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR
Signaling | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Signaling | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K/AKT/mTOR signaling.
TW Grunt, GL Mariani - Current Cancer Drug Targets, 2013 - europepmc.org
Breast cancer is one of the most prevalent and devastating malignant diseases in women
worldwide. Fortunately, while breast cancer incidence is still increasing, its death rate is …
worldwide. Fortunately, while breast cancer incidence is still increasing, its death rate is …
[PDF][PDF] Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling
TW Grunt, GL Mariani - Current Cancer Drug Targets, 2013 - researchgate.net
Breast cancer is one of the most prevalent and devastating malignant diseases in women
worldwide. Fortunately, while breast cancer incidence is still increasing, its death rate is …
worldwide. Fortunately, while breast cancer incidence is still increasing, its death rate is …
Novel approaches for molecular targeted therapy of breast cancer: Interfering with PI3K/AKT/mTOR signaling
TW Grunt, GL Mariani - Current Cancer Drug Targets, 2013 - hero.epa.gov
Breast cancer is one of the most prevalent and devastating malignant diseases in women
worldwide. Fortunately, while breast cancer incidence is still increasing, its death rate is …
worldwide. Fortunately, while breast cancer incidence is still increasing, its death rate is …
Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K/AKT/mTOR signaling
TW Grunt, GL Mariani - Current cancer drug targets, 2013 - pubmed.ncbi.nlm.nih.gov
Breast cancer is one of the most prevalent and devastating malignant diseases in women
worldwide. Fortunately, while breast cancer incidence is still increasing, its death rate is …
worldwide. Fortunately, while breast cancer incidence is still increasing, its death rate is …